{"version":"1.0","type":"link","title":"Efficacy and safety of adjuvant capecitabine and pembrolizumab in early-stage triple-negative breast cancer after standard neo-/adjuvant chemotherapy: A meta-analysis of phase III studies.","author_name":"Ben Kridis W 외","author_url":"https://prs-insight.online/author/Ben%20Kridis%20W","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/89756","thumbnail_width":1200,"thumbnail_height":630}